APA

Imada T., Moriya K., Uchiyama M., Inukai N., Hitotsuyanagi M., Masuda A., Suzuki T., Ayukawa S., Tagawa Y., Dohmae N., Kohara M., Yamamura M. & Kiga D. (20191003). A Highly Bioactive Lys-Deficient IFN Leads to a Site-Specific Di-PEGylated IFN with Equivalent Bioactivity to That of Unmodified IFN-α2b. : ACS synthetic biology.

Chicago

Imada Takashi, Moriya Koji, Uchiyama Masahiko, Inukai Naoto, Hitotsuyanagi Mitsuhiro, Masuda Akiko, Suzuki Takehiro, Ayukawa Shotaro, Tagawa Yo-Ichi, Dohmae Naoshi, Kohara Michinori, Yamamura Masayuki and Kiga Daisuke. 20191003. A Highly Bioactive Lys-Deficient IFN Leads to a Site-Specific Di-PEGylated IFN with Equivalent Bioactivity to That of Unmodified IFN-α2b. : ACS synthetic biology.

Harvard

Imada T., Moriya K., Uchiyama M., Inukai N., Hitotsuyanagi M., Masuda A., Suzuki T., Ayukawa S., Tagawa Y., Dohmae N., Kohara M., Yamamura M. and Kiga D. (20191003). A Highly Bioactive Lys-Deficient IFN Leads to a Site-Specific Di-PEGylated IFN with Equivalent Bioactivity to That of Unmodified IFN-α2b. : ACS synthetic biology.

MLA

Imada Takashi, Moriya Koji, Uchiyama Masahiko, Inukai Naoto, Hitotsuyanagi Mitsuhiro, Masuda Akiko, Suzuki Takehiro, Ayukawa Shotaro, Tagawa Yo-Ichi, Dohmae Naoshi, Kohara Michinori, Yamamura Masayuki and Kiga Daisuke. A Highly Bioactive Lys-Deficient IFN Leads to a Site-Specific Di-PEGylated IFN with Equivalent Bioactivity to That of Unmodified IFN-α2b. : ACS synthetic biology. 20191003.